@Crissmosp ¿De cualquier vacuna? De muchas debe haber metaanálisis... Revisión Cochrane de vacuna neumocócica, ref a 12 estudios randomizados y con grupo control https://t.co/05rSQQHLjk
Предотвращает ли инъекционная пневмококковая вакцина пневмонию у людей с ХОБЛ? https://t.co/WLmTTDnMlx
RT @JuanGrvas: Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
RT @JuanGrvas: Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
RT @JuanGrvas: Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
RT @JuanGrvas: Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
RT @InfeccSoMaMFYC: Vacuna neumocócica en EPOC https://t.co/nww1UpNlMl
@InfeccSoMaMFYC Vacuna neumocócica en EPOC https://t.co/uJAdO6lJpQ
Vacuna neumocócica en EPOC https://t.co/nww1UpNlMl
Confirmation bias, aka "myside" bias https://t.co/WFUqQFqLlO https://t.co/R0cAMzEFdq
El sesgo de confirmación https://t.co/2f76P0MiPg https://t.co/ikNJRiZH9f
RT @JuanGrvas: Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
Vacuna neumococos en pacientes con EPOC. Sin impacto en la mortalidad. https://t.co/joTjcSqXRH
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. No impact on mortality. https://t.co/joTjcSqXRH
RT @davsrodrigues: Pneumococcal vaccine - NNT for an additional beneficial outcome (NNTB) (preventing one episode of CAP) = 21 (95% CI 15 t…
Pneumococcal vaccine - NNT for an additional beneficial outcome (NNTB) (preventing one episode of CAP) = 21 (95% CI 15 to 74). https://t.co/aT5MSkObha
"Vaccination reduced the likelihood of COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination" https://t.co/ozAa5xfRNi
New NNT→Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. https://t.co/QRuL5ZxIG8
The best bit: if you try to check the declarations of interests, it leads to a web page that doesn't exist: https://t.co/yvkU06CuBr
Here are the results for the update of the same review. Would you expect an explanation in the text for the change? https://t.co/yvkU06CuBr https://t.co/PoGXa7OQT5
RT @Actual_clinica: Las vacunas antineumocócicas inyectables, ¿previenen la neumonía en pacientes con EPOC? Cochrane https://t.co/4YCNhpB…
RT @Actual_clinica: Las vacunas antineumocócicas inyectables, ¿previenen la neumonía en pacientes con EPOC? Cochrane https://t.co/4YCNhpB…
Las vacunas antineumocócicas inyectables, ¿previenen la neumonía en pacientes con EPOC? Cochrane https://t.co/4YCNhpBp8a
RT @JesusmRedondo: Las vacunas antineumocócicas reducen las exacerbaciones de EPOC https://t.co/I4uNhXjOEZ
RT @JesusmRedondo: Las vacunas antineumocócicas reducen las exacerbaciones de EPOC https://t.co/I4uNhXjOEZ
RT @JesusmRedondo: Las vacunas antineumocócicas reducen las exacerbaciones de EPOC https://t.co/I4uNhXjOEZ
RT @JesusmRedondo: Las vacunas antineumocócicas reducen las exacerbaciones de EPOC https://t.co/I4uNhXjOEZ
Las vacunas antineumocócicas reducen las exacerbaciones de EPOC https://t.co/I4uNhXjOEZ
RT @neilhardy999: @CarlaAstles Pneumococcal vaccines for preventing pneumonia in chro.... https://t.co/AiHrk7XITk
RT @neilhardy999: @CarlaAstles Pneumococcal vaccines for preventing pneumonia in chro.... https://t.co/AiHrk7XITk
@CarlaAstles Pneumococcal vaccines for preventing pneumonia in chro.... https://t.co/AiHrk7XITk
RT @cochrane_nz: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD https:…
RT @cochrane_nz: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD https:…
RT @cochrane_nz: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD https:…
#CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD https://t.co/kedKQOuAAZ https://t.co/rvnYVQSCix
Cochrane metaanal: Pneumococcal vaccine 💉 significantly protect against CA-pneumonia in COPD https://t.co/widcwYDgoZ @accpinfdprn @SIDPharm
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
Vacinación antineumocócica en EPOC: https://t.co/jbUuCutkp0
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. - PubMed - NCBI https://t.co/hWFNuSYhxP
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
RT @CochraneLibrary: #CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD ht…
#CochraneEvidence: pneumococcal vaccines offer significant protection against community-acquired pneumonia in #COPD https://t.co/TbM0YzMfVc
RT @pfanderson: Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. - PubMed - NCBI https://t.co/sDmh1…
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. - PubMed - NCBI https://t.co/sDmh19XcQ4
Do injectable pneumococcal vaccines prevent pneumonia in people with COPD? | Cochrane https://t.co/S6JJK2I7G6
RT @pontealdiaAP: T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y http…
RT @pontealdiaAP: T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y http…
@rincondesisifo sin patrocinar no diferencias https://t.co/lqSoEgYSMl
RT @FarmaciaOesteAP: (Cochrane) La vacuna del neumococo proporciona protección contra la neumonía en pacientes con EPOC https://t.co/0MV5k…
RT @pontealdiaAP: T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y http…
Do injectable pneumococcal vaccines prevent pneumonia in people with COPD? https://t.co/k4C7cG6RQa
RT @rincondesisifo: (Cochrane) La vacuna antineumocócica, eficaz en la prevención de NAC en pac con EPOC https://t.co/7yvjNS9GH5
RT @FarmaciaOesteAP: (Cochrane) La vacuna del neumococo proporciona protección contra la neumonía en pacientes con EPOC https://t.co/0MV5k…
RT @pontealdiaAP: T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y http…
RT @pontealdiaAP: T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y http…
T2E1A2 neumo23: baja eficacia en>65a, pero previene NAC y exacerb EPOC via @rincondesisifo https://t.co/Eu0SACpT7G y https://t.co/ojkTNDjfly
RT @FarmaciaOesteAP: (Cochrane) La vacuna del neumococo proporciona protección contra la neumonía en pacientes con EPOC https://t.co/0MV5k…
(Cochrane) La vacuna del neumococo proporciona protección contra la neumonía en pacientes con EPOC https://t.co/0MV5kAxiGB
RT @rincondesisifo: (Cochrane) La vacuna antineumocócica, eficaz en la prevención de NAC en pac con EPOC https://t.co/7yvjNS9GH5
(Cochrane) La vacuna antineumocócica, eficaz en la prevención de NAC en pac con EPOC https://t.co/7yvjNS9GH5
Do injectable pneumococcal vaccines prevent pneumonia in people with COPD? @cochranecollab https://t.co/Cn8mpXLHju #cochrane #feedly
Do injectable pneumococcal vaccines prevent pneumonia in people with COPD? https://t.co/WGr6xj28jb
Do injectable pneumococcal vaccines prevent pneumonia in people with COPD?: https://t.co/YzCOznr4N4